Sanofi Adds Firepower in Exiting $13 Billion Regeneron Stake

(Bloomberg) -- Sanofi is selling a stake in Regeneron Pharmaceuticals Inc. valued at about $13 billion, giving the French drugmaker more firepower to potentially snap up promising assets in the can...